# Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

> **NCT00673725** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 49 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Locobase® REPAIR

## Key facts

- **NCT ID:** NCT00673725
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673725, "Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00673725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*